Coregcr
Product Images NDC 54868-0106

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Coregcr (NDC 54868-0106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carvedilol Phosphate Chemical Structure (052358aa A002 42d1 9749 384d97999d07 01)

Chemical structure of the active ingredient in COREGCR CR, showing its molecular components including a phosphate and water of hydration (H3PO4 and H2O).*

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (052358aa A002 42d1 9749 384d97999d07 02)

A line graph showing percent mortality over a 21-month period comparing two groups: one labeled Placebo and the other Carvedilol. The graph illustrates lower mortality rates in the Carvedilol group compared to the Placebo, with a noted significance value of P = 0.0014.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (052358aa A002 42d1 9749 384d97999d07 03)

A forest plot showing hazard ratios for various subgroups including men, women, age groups, race, diabetic status, ischemic status, heart rate categories, systolic blood pressure categories, and spironolactone use. Each subgroup is represented by a point estimate with confidence intervals plotted along a horizontal axis marked with hazard ratio values from 0.0 to 2.0.*

FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (052358aa A002 42d1 9749 384d97999d07 04)

A line chart comparing the percent mortality over 24 months between two groups: Placebo and Carvedilol. The x-axis represents time in months, and the y-axis represents percent mortality. The Placebo group shows higher mortality over time compared to the Carvedilol group, with a P value of 0.03 indicated.*

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (052358aa A002 42d1 9749 384d97999d07 05)

A figure presenting hazard ratios with confidence intervals for various patient subgroups. The subgroups include age (<70, ≥70), gender (men, women), randomization timing post-myocardial infarction, prior intravenous/oral beta-blocker use, Killip class, thrombolytic therapy, percutaneous transluminal coronary angioplasty for myocardial infarction, congestive heart failure status, use of diuretics during myocardial infarction, presence of angina, hypertension, diabetes, heart rate, and systolic blood pressure. Each subgroup is plotted along a horizontal hazard ratio axis from 0.4 to 1.3.*

FDA Label Image

Figure 5. Changes From Baseline In Systolic Blood Pressure And Diastolic Blood Pressure Measured By 24-hour Abpm (052358aa A002 42d1 9749 384d97999d07 06)

Two line graphs showing the change in systolic blood pressure (SBP) and diastolic blood pressure (DBP) over 24 hours after a morning dose of COREG CR at 20 mg, 40 mg, and 80 mg strengths. The x-axis represents time in hours, and the y-axis represents blood pressure change in mmHg. Lines were smoothed using locally weighted regression smoothing methodology.*

FDA Label Image

Coreg Cr 10 mg Label (10mg Package Label)

Packaging label for COREGCR CR 10 mg capsules distributed by Physicians Total Care, Inc., showing NDC 54868-6019-0. The label includes lot number 0000 and expiration date 01/60, along with the manufacturer listed as Glaxo Smith Kline, Research Triangle NC.*

FDA Label Image

Coreg Cr 20mg Label (20mg Package Label)

COREGCR CR 20 mg extended-release capsules, labeler Physicians Total Care, Inc. The label shows 90 capsules per bottle. It includes dosing and dispensing cautions, storage instructions, and the product's NDC 54868-0106-1. The label also contains a barcode and lot number information.*

FDA Label Image

Coreg Cr 40mg Label (40mg Package Label)

Label for COREGCR CR 40mg extended-release capsules from Physicians Total Care, Inc. The label indicates a 90-capsule quantity and includes a federal caution against dispensing without prescription. It displays the NDC number and storage instructions, along with usage warnings and a barcode.*

FDA Label Image

Coreg Cr 80mg Label (80mg Package Label)

COREGCR CR 80mg extended-release capsules packaging label by Physicians Total Care, Inc. The label includes the active ingredient carvedilol phosphate and indicates 90 capsules per container. It has dosage information, caution about prescription dispensing, and storage instructions. The label features barcodes, lot number, and expiration date details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.